Study Reveals LEMS Often Goes Undiagnosed in U.S. Patients with Small Cell Lung CancerCORAL GABLES, Fla., Aug. 16, 2023 Catalyst Pharmaceuticals, Inc. , a commercial-stage, patient-centric. -Today at 10:57 am- MarketScreener
Ruzurgi® (amifampridine) BLAINVILLE, Quebec, July 11, 2023 (GLOBE NEWSWIRE) — Médunik Canada, member of Duchesnay Pharmaceutical Group, is pleased to announce…